141 related articles for article (PubMed ID: 38737340)
1. Protective effects of dopamine against non-alcoholic steatohepatitis via inhibiting p65 pathways in vivo and in vitro.
Ma P; Wang X; Wen X; Pu L; Ou Y
Toxicol Res (Camb); 2024 Jun; 13(3):tfae068. PubMed ID: 38737340
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice.
Li N; Zhu C; Fu R; Ma X; Duan Z; Fan D
Phytomedicine; 2024 Feb; 124():155287. PubMed ID: 38176268
[TBL] [Abstract][Full Text] [Related]
3. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
[TBL] [Abstract][Full Text] [Related]
4. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
5. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
6. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways.
Liu G; Cui Z; Gao X; Liu H; Wang L; Gong J; Wang A; Zhang J; Ma Q; Huang Y; Piao G; Yuan H
Phytother Res; 2021 Sep; 35(9):5214-5226. PubMed ID: 34213784
[TBL] [Abstract][Full Text] [Related]
7. Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway.
Wang MY; Zhang SS; An MF; Xia YF; Fan MS; Sun ZR; Zhang LJ; Zhao YL; Sheng J; Wang XJ
Phytomedicine; 2023 Jun; 114():154798. PubMed ID: 37031639
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
9. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
El-Derany MO; El-Demerdash E
Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis.
Xu L; Zhang Y; Ji N; Du Y; Jia T; Wei S; Wang W; Zhang S; Chen W
Exp Ther Med; 2022 Jul; 24(1):486. PubMed ID: 35761808
[TBL] [Abstract][Full Text] [Related]
11. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage.
Segal-Salto M; Barashi N; Katav A; Edelshtein V; Aharon A; Hashmueli S; George J; Maor Y; Pinzani M; Haberman D; Hall A; Friedman S; Mor A
JHEP Rep; 2020 Feb; 2(1):100064. PubMed ID: 32039405
[TBL] [Abstract][Full Text] [Related]
12. Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice.
Xu J; He X; Huang X; Zhang F; Ren X; Asakiya C; Li Y; Huang K
Front Pharmacol; 2022; 13():851342. PubMed ID: 35586049
[No Abstract] [Full Text] [Related]
13. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
14. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
[TBL] [Abstract][Full Text] [Related]
15. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
16. Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-
Yang XD; Chen Z; Ye L; Chen J; Yang YY
Pharm Biol; 2021 Dec; 59(1):922-932. PubMed ID: 34243681
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro.
Xue Y; Wei Y; Cao L; Shi M; Sheng J; Xiao Q; Cheng Z; Luo T; Jiao Q; Wu A; Chen C; Zhong L; Zhang C
J Ethnopharmacol; 2024 Jan; 318(Pt A):116933. PubMed ID: 37482263
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
19. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
20. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
